EUROPEAN DELIRIUM ASSOCIATION ANNUAL MEETING 2024 - SAVE THE DATE


​TEAM UP AGAINST DELIRIUM! 
​THE HAGUE, THE NETHERLANDS, 6-8 NOVEMBER 2024


Team up against delirium with keynote speakers Carsten Hermes, Meera Agar, and Bjorn Weiss!

We warmly encourage the submission of original research for oral presentations and posters. Abstracts can be submitted via the conference website: https://www.edaconference.nl/

We are also accepting proposals for submitted symposia. You are invited to send these to the conference organisation via: [email protected].

​What we do, What You can Do

Delirium is a common and potentially serious medical condition that can affect the elderly, the frail, the sick, the cognitively impaired - but more generally: everyone - given "stressing" events.

​These may include - among others - infections, operations, change in  or withdrawal  from  medication, sensory deprivation  or even simply removal from one's familiar environment such as hospitalization.

Delirium is a state of acute confusion.
What we do?
​​The European Delirium Association is a professional association providing a platform  for practitioners,  researchers, policy makers and other interested to network for the benefit of patients.
Our goal is to move forward with all those dedicated to delirium  care and research, joining efforts to  promote the disorder's visibility  not only in the general public, but also in the medical professional setting.
What you can do?
​Join us in this endeavour, by:

EDA webinars

The European Delirium Association has organised a number of free webinars on a variety of topics around delirium. If you are interested, please take a look at our EDA webinars page for the recordings. 

EDA newsletters

The European Delirium Association delivers a newsletter with content about research in delirium to date.
​If you are interested, please take a look at our latest newsletter. 

...and while you are here, why not become a member?

twitter

As Twitter has gone on to X and its CEO is who he is, embedding Twitter/X feeds is not a consistent experience; so if you're "seeing nothing here" click on "View on Twitter" to see ...

lATEST nEWS

Now accepting nominations for the maeve leonard award 2024!

All EDA members are encouraged to propose individuals or groups who they believe should be considered for the award in 2024. 

The Maeve Leonard Award is awarded annually to an individual (or group) who has made a very significant contribution to delirium awareness, knowledge or care. The Award is given in memory of Dr Maeve Leonard, a Liaison Psychiatrist, a gifted teacher and a committed researcher in the assessment and management of symptoms of delirium in hospitalised patients. Maeve was described as a ‘tsunami of positivity’ and the energy and commitment she brought to delirium research and care is remembered in this reward. 

eUgms congress - vALENCIA, sPAIN

Members of the EDA are invited to join the upcoming 20th European Geriatric Medicine Society (EuGMS) congress in Valencia, Spain, from September 18th - 20th, 2024. 

This years theme is  From Healthy Ageing to Complex Needs in Older Adults.

The scope is broad and appealing with something for everybody – clinicians, clinical scientists, trainees, educationalists, and health service researchers. Moreover, the programme will highlight state-of-the-art clinical practices, recent advances, new data, and views from different stakeholders, in a format designed to encourage interaction and collaboration.

Network for investigation of delirium: unifying scientists pilot awards 2025-2026

The Network for Investigation of Delirium: Unifying Scientists is awarding two $40,000 Pilot Awards for the 2025-2026 grant cycle. This cycle of Pilot Awards is focused on the inter-relationship of Delirium and Alzheimer’s Disease and Related Dementias (AD/ADRD). This focus is purposefully broad, and examples of projects fulfilling this theme include (but are not limited to) studies focused on:

  • Risk factors or outcomes related to delirium associated with AD/ADRD or long-term cognitive decline.
  • Harmonization and refinement of measurement tools that distinguish delirium from AD/ADRD or delirium superimposed on AD/ADRD
  • Biomarker and mechanistic studies to advance our understanding of: (1) the pathophysiology of inter-relationship of delirium and AD/ADRD; (2) how delirium may lead to the development of AD/ADRD; or (3) identifying therapeutic targets at the interface of delirium and AD/ADRD
  • Clinical Trials--Intervention development studies for future clinical trials, especially of delirium prevention or treatment strategies which examine effectiveness for the outcomes of AD/ADRD or long-term cognitive decline
 
To learn more about our Pilot Awards and participate in a Q&A session, register here for the informational session on Wednesday November 6, 2024 from 12-1pm EST.
 
Pilot Letters of Intent are due on Friday December 6, 2024 by 5pm EST.
 
All deadlines can be found on the timeline on the Pilots page of the NIDUS website, as well as all instructions and eligibility criteria for LOIs and the full Pilot applications.